This month the 33rd Annual Meeting of the European Society for Hyperthermic Oncology (ESHO 2019) will be held in Warsaw, Poland, at the Warsaw Plaza Hotel, on May 22 - 24, 2019. The conference invites thermal oncology professionals with extensive clinical and scientific experience to share their expertise in the field.
Pyrexar Medical is represented by our European distribution partner Dr. Sennewald Medizintechnik and Poland distributor HT Systems.
Pyrexar Represented by: |
 |
 |
The conference includes over 58 presentations by leading hyperthermia experts. Highlights below:
| MR thermometry validation and modeling of a 915 MHz annular phased-array in brain phantoms | Paul Turner |
| A meta-analysis of clinical trials with hyperthermia | Niloy Datta |
| Protons and hyperthermia: early clinical results | Zeljko Vujaskovic |
| Building an international forum to boost hyperthermic research | Stephan Bodis |
| Quality assurance guidelines for hyperthermia | H. Dobsicek Trefna |
| Quality assurance assessment: are commercial MR-guided deep-pelvic hyperthermia devices ready for a large clinical trial? | Sergio Curto |
| QA techniques for radiative deep hyperthermia systems: benefits and limitations of 1D, 2D, and 3D techniques | Gerard van Rhoon |
| Combined interstitial radiotherapy with interstitial hyperthermia | Andrzej Kukielka |
| Thermochemoradiotherapy for locally advanced pancreatic cancers: A pilot study | Niloy Datta |
| Radiotherapy in combination with regional Hyperthermia for Salvage Treatment in refractory Childhood Cancer | Rudiger Wessalowski |
| Full program available here. | |
A special thanks to the 2019 ESHO committee for organizing this year's event and to the Maria Sklodowska-Curie Institute — Oncology Center for hosting the hyperthermia workshops.
Dr. Ruediger Wessalowski awarded the prestigious J. Eugene Robinson Award. The J. Eugene Robinson Award is presented each year to an investigator who has made outstanding contributions to hyperthermic oncology. Dr. Wessalowski practices at the Clinic for Pediatric Oncology, Hematology, and Clinical Oncology at the 
Chris Diederich, Ph.D., was honored with the George M. Hahn Award. The George M. Hahn Award is presented every other year to an investigator whose research has contributed in a significant way to new clinical applications in thermal therapy. Professor Diederich is the Director of Clinical Hyperthermia Physics and Thermal Therapy Research at the University of California, San Francisco. The Pyrexar BSD-500 and BSD-2000 hyperthermia systems are in practice at the 
